- Oral extended release
drug delivery medication will continue to account for the largest share
of drug delivery systems. The extended release product will optimize
therapeutic effect and safety of a drug at the same time improving the
patient convenience and compliance.
- Extended release
products have many advantages
- Matrix system is
widely used for the
purpose of sustained release
- The matrix system can
be divided into two categories depending on the types of retarding
agents or polymeric materials.
1) Hydrophobic matrix system
2) Hydrophilic matrix system
3) Fat-wax matrix system
- Unlike reservoir and
osmotic systems, products based on matrix design can be manufactured
using conventional processes and equipments
- Potassium citrate
Extended-Release Tablets, is an oral preparation of
potassium citrate which is imbedded in wax matrix to insure slow
release. The main
physiological response to potassium citrate treatment is a rise in
urinary citrate and urinary pH, largely a consequence of the alkali
load, rather than the appearance in urine of administered citrate.
|
Basic
Information
-
Extended Release Matrix Technology
-
Extended release
drug delivery Technology
-
Product
Profile
Products
Information
- Prescribing Information
- Wax Matrix Tablets
- Product details
- Product Monograph
- Product Specification
- Full prescription data
- Three Potassium Citrate - 1 Hydrates PRS
- Three-potassium citrate 1-hydrate
- Potassium
citrate monohydrate
- Potassium
Citrate
- Chewable Tablets
- Potassium
Citrate - food additive
- Potassium
Citrate
- Certificate of
analysis
Raw Material
Suppliers
-
Potassium Citrate suppliers
-
Pharma Grade raw
materials
-
Ingredient
supplier
Patents
-
Company in Patent dispute
- Controlled
release dosage form
|
Company
Performances
- Major Player
- Company - Financial performance
- Company presentation
- Consultant's Report
Technology Information
-
Guidance on Potassium Citrate
- Research support
- Preparing
controlled release tablets
- Carnauba
wax as a carrier for aroma encapsulation
- Wax-lipid based
materials
- Development and evaluation of
sustained release losartan potassium matrix tablet using kollidon SR as
release retardant
- Release
Process for a Reservoir Device Tablet
- Design & Evaluation Prolonged Release
- case study
Market Scenario
- Generic Drug Marketplace
- International Trade commission report
- Application
- News - Controlled
release alliance
- Marketing
Information
- Drug List -
2013
- Historical Data
Order the CD ROM Today |